Department of Chemistry, Korea University, Seoul 02841, Korea.
Chem Soc Rev. 2020 Jun 7;49(11):3244-3261. doi: 10.1039/c9cs00648f. Epub 2020 Apr 27.
Phototherapy, including photodynamic therapy and photothermal therapy, has the potential to treat several types of cancer. However, to be an effective anticancer treatment, it has to overcome limitations, such as low penetration depth, low target specificity, and resistance conferred by the local tumor microenvironment. As a non-invasive technique, low-intensity ultrasound has been widely used in clinical diagnosis as it exhibits deeper penetration into the body compared to light. Recently, sonodynamic therapy (SDT), a combination of low-intensity ultrasound with a chemotherapeutic agent (sonosensitizer), has been explored as a promising alternative for cancer therapy. As all known cancer treatments such as chemotherapy, photodynamic therapy, photothermal therapy, immunotherapy, and drug delivery have been advanced independently enough to complement others substantially, the combination of these therapeutic modalities with SDT is opportune. This review article highlights the recent advances in SDT in terms of sonosensitizers and their formulations and anticancer therapeutic efficacy. Also discussed is the potential of SDT in combination with other modalities to address unmet needs in precision medicine.
光疗,包括光动力疗法和光热疗法,具有治疗多种癌症的潜力。然而,要成为一种有效的抗癌治疗方法,它必须克服一些限制,如低穿透深度、低靶向特异性以及局部肿瘤微环境赋予的耐药性。作为一种非侵入性技术,低强度超声在临床诊断中得到了广泛应用,因为它比光具有更深的穿透深度。最近,声动力学疗法(SDT),即低强度超声与化疗药物(声敏剂)的结合,已被探索作为癌症治疗的一种有前途的替代方法。由于所有已知的癌症治疗方法,如化疗、光动力疗法、光热疗法、免疫疗法和药物输送,都已经足够先进,可以相互补充,因此将这些治疗方式与 SDT 相结合是适时的。本文综述了 SDT 在声敏剂及其制剂和抗癌治疗效果方面的最新进展。还讨论了 SDT 与其他方式结合的潜力,以满足精准医学中未满足的需求。